Magnum Ice Cream Co N.V. (MICC)

Price—Loading quote

AI: Fair-priced

Price checkThe shares look fairly priced because recovery is visible, but the market already expects substantial improvement.

At the latest euro-market equivalent, the equity is worth about €10.7 billion. That is roughly 19 times 2025 adjusted earnings per share of €0.93—profit per share after removing management-defined unusual items—versus about 36 times statutory earnings of €0.48. A simple 2026 scenario of €0.95–€1.10 adjusted earnings per share implies about 16–18 times earnings. Net debt—borrowings minus cash—was €3.26 billion at June. This is reasonable only if management sustains 3–5% organic sales growth, excluding acquisitions and currency effects, plus 40–60 basis points of comparable profit-margin improvement; 100 basis points equals one percentage point.

Big pictureProfit and cash fell sharply in 2025, while early 2026 shows a meaningful but incomplete rebound.

The supplied history shows revenue was nearly flat at €7.91 billion in 2025, while operating income fell to €599 million from €764 million and net income to €293 million from €579 million. Operating cash flow dropped to €483 million as capital spending rose to €357 million; company-defined free cash flow, cash left after operations, capital spending and net interest, fell to €38 million from €803 million. First-half 2026 free cash flow recovered to €273 million, but €173 million came from a transition-related cash-timing benefit. Ice cream is summer-weighted, so first-half results cannot simply be doubled.

Business strengthGlobal brands support steady demand, but heavier debt and employee awards reduce financial flexibility.

Magnum owns four of the five largest global ice-cream brands and reports about 21% global retail share, supported by three million freezer cabinets. Organic sales grew 4.2% in 2025 and 4.7% in the first half of 2026, with volume and pricing contributing. Net debt reached €3.26 billion, about 2.6 times 2025 adjusted operating cash earnings. Shares stayed near 612 million, while 10.95 million executive options equal potential dilution of about 1.8%; planned purchases of up to 5.5 million shares partly cover that. The dividend policy is 40–60% of earnings from 2026, while Unilever’s 19.85% retained stake remains future market supply.

What could change the storySavings and volume growth could lift value, while weak cash conversion or Turkey restrictions could break the case.

The bull case is the €500 million productivity program: €90 million of savings arrived in the first half, and management still targets 3–5% organic growth plus 40–60 basis points of comparable yearly profit-margin improvement. The bear case is that 2025 cash weakness proves structural once transition benefits fade. Turkey is a concrete test: regulators required 30% of certain company-owned freezer capacity to hold rivals’ products or remain empty. A stronger thesis needs sustainable annual free cash flow above roughly €500 million; repeated weakness below that level would make today’s valuation hard to defend.

AI: News

Buyout interest surfacedReported takeover interest sparked a sharp rally, but no bid exists and deal restrictions remain.

On May 15, Reuters reported that Blackstone and Clayton, Dubilier & Rice were among investment firms exploring possible bids, with decisions expected to depend partly on summer trading. The report said discussions were preliminary and no offer had been made. London-listed shares jumped about 17% intraday, making this the clearest recent price-moving event. Investors should separate takeover optionality from business value: tax rules from Magnum’s split from Unilever may restrict major transactions for roughly two years, and interest could disappear if operating results disappoint.

Half-year results beatHalf-year earnings beat expectations, yet unchanged guidance kept investors from rewarding the shares much.

On July 30, Magnum reported first-half 2026 adjusted operating cash earnings of €880 million versus company-compiled consensus of €843 million. Organic sales growth was 4.7%, above the 3.4% forecast cited by Reuters, and €90 million of productivity savings had been delivered. Management still guided to 3–5% organic sales growth and 40–60 basis points of comparable profit-margin improvement for 2026. Reuters reported the shares were little changed by midday after an early dip, so the market reaction was muted despite the earnings beat.

Employee share purchasesShare purchases for employee plans reduce dilution pressure, but they spend cash rather than retire stock.

On August 18, Magnum said it would enter forward contracts to acquire up to 5.5 million shares for employee incentive obligations, representing about 0.9% of shares outstanding and roughly €90 million at the announcement’s market level. By August 21, about 1.36 million shares had been purchased for roughly €22.8 million. These are not ordinary cancellation buybacks; the shares are intended for an employee benefit trust. They can reduce future award-related issuance pressure, but they also consume cash, and any support to the share price is uncertain.

Loading local price history

Revenue

2022

2023

2024

2025

Net income

2022

2023

2024

2025

Free cash flow

2022

2023

2024

2025

Total cash / debt

CashTotal debt

2022

2023

2024

2025

Financial statements

	2025	2024	2023	2022
Revenue	€7.91B	€7.95B	€7.62B	€7.51B
Gross profit	€2.74B	€2.77B	€2.60B	€2.57B
Gross margin	34.63%	34.91%	34.08%	34.19%
Research & development	€88.0M	€92.0M	€92.0M	€95.0M
Operating expenses	€2.14B	€2.01B	€1.85B	€1.70B
Operating income	€599.0M	€764.0M	€742.0M	€866.0M
Operating margin	7.57%	9.61%	9.74%	11.54%
EBITDA	€937.0M	€1.14B	€1.10B	€1.10B
EBITDA margin	11.85%	14.35%	14.43%	14.67%
Net income	€307.0M	€595.0M	€509.0M	€509.0M
Net profit margin	3.88%	7.49%	6.68%	6.78%
Basic EPSper basic share	€0.48	€0.95	€0.80	€0.83
Diluted EPSper diluted share	€0.48	€0.95	€0.80	€0.83